Studies how TREM2 and other innate-immune pathways regulate microglial responses to amyloid and tau pathology. Uses mouse models to determine how TREM2-dependent functions influence plaque toxicity, tau-mediated neurodegeneration, and the potential value of TREM2 as a therapeutic target.